Clinical Trial Update: PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating PD-1 antibody with chemoradiotherapy for locally advanced cervical cancer (IB2-IIIB).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Lei Li | Conditions: Cervical Carcinoma, Chemoradiotherapy | Phase 2 | Status: UNKNOWN